Grape King Bio Ltd (1707) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, Grape King Bio Ltd (1707) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$161.09 Million ≈ $5.08 Million USD) by net assets (NT$11.64 Billion ≈ $366.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Grape King Bio Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Grape King Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Grape King Bio Ltd total liabilities for a breakdown of total debt and financial obligations.

Grape King Bio Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Grape King Bio Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nanjing Central Emporium Group Stocks Co Ltd SHG:600280	0.109x
Gulf Oil Lubricants India Limited NSE:GULFOILLUB	0.014x
Rigel Pharmaceuticals Inc NASDAQ:RIGL	0.056x
Man Infraconstruction Limited NSE:MANINFRA	0.007x
Canadian Banc Corp TO:BK	0.022x
HCM II Acquisition Corp. Unit NASDAQ:HONDU	-0.002x
Meridian Mining UK Societas TO:MNO	-0.079x
Optotech Corp TW:2340	-0.010x

Annual Cash Flow Conversion Efficiency for Grape King Bio Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Grape King Bio Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Grape King Bio Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$11.79 Billion ≈ $371.47 Million	NT$1.88 Billion ≈ $59.10 Million	0.159x	-26.56%
2023-12-31	NT$11.63 Billion ≈ $366.41 Million	NT$2.52 Billion ≈ $79.37 Million	0.217x	-19.29%
2022-12-31	NT$11.14 Billion ≈ $351.00 Million	NT$2.99 Billion ≈ $94.22 Million	0.268x	+10.12%
2021-12-31	NT$10.43 Billion ≈ $328.58 Million	NT$2.54 Billion ≈ $80.09 Million	0.244x	-28.48%
2020-12-31	NT$7.98 Billion ≈ $251.37 Million	NT$2.72 Billion ≈ $85.67 Million	0.341x	+17.26%
2019-12-31	NT$7.47 Billion ≈ $235.37 Million	NT$2.17 Billion ≈ $68.41 Million	0.291x	-16.64%
2018-12-31	NT$6.93 Billion ≈ $218.44 Million	NT$2.42 Billion ≈ $76.16 Million	0.349x	-11.59%
2017-12-31	NT$6.33 Billion ≈ $199.37 Million	NT$2.50 Billion ≈ $78.63 Million	0.394x	-18.64%
2016-12-31	NT$5.78 Billion ≈ $182.19 Million	NT$2.80 Billion ≈ $88.31 Million	0.485x	+56.50%
2015-12-31	NT$4.22 Billion ≈ $132.94 Million	NT$1.31 Billion ≈ $41.18 Million	0.310x	-32.34%
2014-12-31	NT$3.72 Billion ≈ $117.10 Million	NT$1.70 Billion ≈ $53.60 Million	0.458x	-6.43%
2013-12-31	NT$3.22 Billion ≈ $101.47 Million	NT$1.58 Billion ≈ $49.65 Million	0.489x	+19.64%
2012-12-31	NT$2.74 Billion ≈ $86.39 Million	NT$1.12 Billion ≈ $35.33 Million	0.409x	+19.10%
2011-12-31	NT$2.47 Billion ≈ $77.86 Million	NT$848.53 Million ≈ $26.73 Million	0.343x	+13.46%
2010-12-31	NT$2.26 Billion ≈ $71.20 Million	NT$683.89 Million ≈ $21.55 Million	0.303x	-12.82%
2009-12-31	NT$2.08 Billion ≈ $65.40 Million	NT$720.61 Million ≈ $22.70 Million	0.347x	+39.24%
2008-12-31	NT$1.74 Billion ≈ $54.95 Million	NT$434.85 Million ≈ $13.70 Million	0.249x	+74.65%
2007-12-31	NT$1.77 Billion ≈ $55.86 Million	NT$253.11 Million ≈ $7.97 Million	0.143x	-48.28%
2006-12-31	NT$1.70 Billion ≈ $53.52 Million	NT$468.84 Million ≈ $14.77 Million	0.276x	+26.09%
2005-12-31	NT$1.60 Billion ≈ $50.42 Million	NT$350.26 Million ≈ $11.04 Million	0.219x	+597.83%
2004-12-31	NT$1.58 Billion ≈ $49.75 Million	NT$49.53 Million ≈ $1.56 Million	0.031x	-65.88%
2003-12-31	NT$1.48 Billion ≈ $46.75 Million	NT$136.42 Million ≈ $4.30 Million	0.092x	+75.77%
2002-12-31	NT$1.46 Billion ≈ $46.03 Million	NT$76.42 Million ≈ $2.41 Million	0.052x	--

About Grape King Bio Ltd

TW:1707 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$525.05 Million

NT$16.67 Billion TWD

Market Cap Rank

#12287 Global

#433 in Taiwan

Share Price

NT$112.50

Change (1 day)

-1.32%

52-Week Range

NT$112.50 - NT$138.50

All Time High

NT$227.99